Furosemide Use in Dialysis Patients

Introduction to Furosemide Therapy

• The American Journal of Kidney Diseases recommends that furosemide can be used in dialysis patients who retain residual urine output, but it should be reserved specifically for those with preserved residual renal function (RRF) and used cautiously with high doses to promote sodium and water loss 1, 2

Primary Indication: Preservation of Residual Renal Function

• Residual renal function is one of the most important predictors of survival in dialysis patients, making its preservation a critical therapeutic goal 1, 2
• Loop diuretics like furosemide can be administered in large doses to promote sodium and water loss in dialysis patients who still produce urine 1, 2, 3
• The therapy is only effective when RRF is high enough to provide daily urine output of at least 100 mL 3

Critical Safety Considerations and Contraindications

• Absolute contraindications include anuria, severe hypovolemia, and severe hyponatremia, as stated by Praxis Medical Insights 4, 5
• Ototoxicity risk is significant, with the incidence being greater with furosemide and torsemide compared to bumetanide, particularly at cumulative doses and with prolonged use 2, 3

Monitoring Requirements

• Electrolytes, blood pressure, and fluid status must be monitored closely, as recommended by Praxis Medical Insights 4, 5
• Assess urine output response to determine ongoing efficacy 5

Role in Volume Management Strategy

• Furosemide should be viewed as an adjunct to, not replacement for, appropriate ultrafiltration during dialysis, according to the American Journal of Kidney Diseases 1, 2
• Dietary sodium restriction and lower dialysate sodium concentrations remain essential for effective volume management 1, 2
• The primary goal is preserving residual renal function, which improves survival, rather than simply managing volume 1, 2